Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes

NCT00383877 Phase 3 COMPLETED

This trial is conducted in China. This trial aims for a comparison of the effect on glycemic control in subjects with type 2 diabetes of insulin detemir or NPH-insulin given once daily at bedtime as add-on to oral anti-diabetic drug(s).

Details

Lead sponsor	Novo Nordisk A/S
Phase	Phase 3
Status	COMPLETED
Enrolment	263
Start date	2006-09
Completion	2007-08

Conditions

• Diabetes
• Diabetes Mellitus, Type 2

Interventions

• insulin detemir
• insulin NPH

Primary outcomes

• HbA1c — after 20 weeks of treatment

Countries

China